526 POSTER Prediction of clinical response of rituximab containing chemotherapy using newly established live-cell-imaging procedure for estimating CDC susceptibility
- 作者Y. Mishima; Y. Terui; N. Sugimura; Y. Mishima; K. Hatake
- 卷第6卷
- 期第12期
- 文件大小57.68KB
- 发表时间2008
- DOI10.1016/s1359-6349(08)72460-1
同作者推荐
Effect of Anti-Ecallantide Antibodies on Tissue Factor Pathway Inhibitor FunctionMartik, D.; Conley, G.; Chen, J.; Comeau, S.R.; Sexton, D.J.; Tenhoor, C. · Journal of Allergy and Clinical Immunology · 2011
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and AngiogenesisDevy, L.; Huang, L.; Naa, L.; Yanamandra, N.; Pieters, H.; Frans, N.; Chang, E.; Tao, Q.; Vanhove, M.; Lejeune, A.; van Gool, R.; Sexton, D. J.; Kuang, G.; Rank, D.; Hogan, S.; Pazmany, C.; Ma, Y. L.; Schoonbroodt, S.; Nixon, A. E.; Ladner, R. C.; Hoet, R.; Henderikx, P.; TenHoor, C.; Rabbani, S. A.; Valentino, M. L.; Wood, C. R.; Dransfield, D. T. · Cancer Research · 2009